The interprofessional management of psychotropic medications in elderly dementia patients residing at an assisted living center

2015 ◽  
Vol 1 (2) ◽  
pp. 58
Author(s):  
Abimbola Farinde
2016 ◽  
Vol 6 (4) ◽  
pp. 1035-1044
Author(s):  
S. Xefteris ◽  
N. Doulamis ◽  
V. Andronikou ◽  
T. Varvarigou ◽  
G. Cambourakis

Behavioral biometrics aim at providing algorithms for the automatic recognition of individual behavioral traits, stemming from a person’s actions, attitude, expressions and conduct. In the field of ambient assisted living, behavioral biometrics find an important niche. Individuals suffering from the early stages of neurodegenerative diseases (MCI, Alzheimer’s, dementia) need supervision in their daily activities. In this context, an unobtrusive system to monitor subjects and alert formal and informal carers providing information on both physical and emotional status is of great importance and positively affects multiple stakeholders. The primary aim of this paper is to describe a methodology for recognizing the emotional status of a subject using facial expressions and to identify its uses, in conjunction with pre-existing risk-assessment methodologies, for its integration into the context of a smart monitoring system for subjects suffering from neurodegenerative diseases. Paul Ekman’s research provided the background on the universality of facial expressions as indicators of underlying emotions. The methodology then makes use of computational geometry, image processing and graph theory algorithms for the detection of regions of interest and then a neural network is used for the final classification. Findings are coupled with previous published work for risk assessment and alert generation in the context of an ambient assisted living environment based on Service oriented architecture principles, aimed at remote web-based estimation of the cognitive and physical status of MCI and dementia patients.


Author(s):  
Radu-Ioan Ciobanu ◽  
Ciprian Dobre

By 2050, 135.5 million people will suffer from dementia worldwide. Ambient Assisted Living (AAL) technologies can help dementia patients enjoy an independent life. In particular, communication is vital to any AAL system. Opportunistic networking uses low-cost wearable devices to exchange packets at a close range in cases where there is limited or no infrastructure. In this chapter, the authors propose and describe an autonomous patient monitoring support system based on opportunistic communication. The monitored patient wears non-intrusive sensors, computing devices and actuators, forming a Body Area Network (BAN). The BAN can provide memory impairment support services for the patient and is used to construct personalized condition-monitoring patient models to evaluate against a set of potential life-threatening events. The authors present two data transfer algorithms and show that they are able to offer good hit rates while decreasing congestion and overhead when compared to other existing solutions.


2016 ◽  
pp. 1017-1047
Author(s):  
Radu-Ioan Ciobanu ◽  
Ciprian Dobre

By 2050, 135.5 million people will suffer from dementia worldwide. Ambient Assisted Living (AAL) technologies can help dementia patients enjoy an independent life. In particular, communication is vital to any AAL system. Opportunistic networking uses low-cost wearable devices to exchange packets at a close range in cases where there is limited or no infrastructure. In this chapter, the authors propose and describe an autonomous patient monitoring support system based on opportunistic communication. The monitored patient wears non-intrusive sensors, computing devices and actuators, forming a Body Area Network (BAN). The BAN can provide memory impairment support services for the patient and is used to construct personalized condition-monitoring patient models to evaluate against a set of potential life-threatening events. The authors present two data transfer algorithms and show that they are able to offer good hit rates while decreasing congestion and overhead when compared to other existing solutions.


2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 706-706
Author(s):  
Paula Carder ◽  
Sheryl Zimmerman ◽  
Christopher Wretman ◽  
Sarah Dys ◽  
Philip Sloane

Abstract This study examined the use of pro re nata (PRN, or as needed) psychotropic medications among assisted living (AL) residents. We examined prescriptions and administrations, and compared use based on dementia diagnosis. Data sources included interviews with administrators of 250 AL communities in 7 states and medication administration record review for the prior 7 days; analyses were weighted to the entire state. The percent of all residents prescribed a PRN psychotropic medication was 10.3%. However, residents with a dementia diagnosis were twice as likely to have a PRN psychotropic prescription (15.2% versus 7.2%; p<.001). The majority of psychotropic medications prescribed and administered were for anxiolytics/hypnotics rather than antipsychotics. Additional resident-level factors significantly associated with higher PRN prescribing included psychiatric diagnosis, incontinence, hospice use, confusion/disorientation, and agitation. We summarize these and other findings in the context of state regulatory requirements for staffing, chemical restraints, and dementia care.


Author(s):  
Paula Carder ◽  
Sheryl Zimmerman ◽  
Christopher J. Wretman ◽  
John S. Preisser ◽  
Sarah Dys ◽  
...  

2003 ◽  
Vol 29 (4) ◽  
pp. 489-524
Author(s):  
Brent Pollitt

Mental illness is a serious problem in the United States. Based on “current epidemiological estimates, at least one in five people has a diagnosable mental disorder during the course of a year.” Fortunately, many of these disorders respond positively to psychotropic medications. While psychiatrists write some of the prescriptions for psychotropic medications, primary care physicians write more of them. State legislatures, seeking to expand patient access to pharmacological treatment, granted physician assistants and nurse practitioners prescriptive authority for psychotropic medications. Over the past decade other groups have gained some form of prescriptive authority. Currently, psychologists comprise the primary group seeking prescriptive authority for psychotropic medications.The American Society for the Advancement of Pharmacotherapy (“ASAP”), a division of the American Psychological Association (“APA”), spearheads the drive for psychologists to gain prescriptive authority. The American Psychological Association offers five main reasons why legislatures should grant psychologists this privilege: 1) psychologists’ education and clinical training better qualify them to diagnose and treat mental illness in comparison with primary care physicians; 2) the Department of Defense Psychopharmacology Demonstration Project (“PDP”) demonstrated non-physician psychologists can prescribe psychotropic medications safely; 3) the recommended post-doctoral training requirements adequately prepare psychologists to prescribe safely psychotropic medications; 4) this privilege will increase availability of mental healthcare services, especially in rural areas; and 5) this privilege will result in an overall reduction in medical expenses, because patients will visit only one healthcare provider instead of two–one for psychotherapy and one for medication.


Sign in / Sign up

Export Citation Format

Share Document